By Rob Curran Shares of ABVC BioPharma more than tripled after the development-stage biopharmaceutical company struck a licensing agreement with AiBtl.
ABVC BioPharma, Inc. (NASDAQ:ABVC – Get Free Report) was the target of a large drop in short interest in the month of September. As of September 30th, there was short interest totalling 14,100 shares, a drop of 26.9% from the September 15th total of 19,300 shares. Approximately 0.6% of the company’s stock are short sold. […]
ABVC BioPharma, Inc. (NASDAQ:ABVC – Get Free Report) was the target of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totalling 19,800 shares, a decrease of 29.8% from the August 15th total of 28,200 shares. Currently, 1.0% of the shares of the stock are […]
ABVC BioPharma (NASDAQ:ABVC – Get Free Report) is one of 937 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its rivals? We will compare ABVC BioPharma to related companies based on the strength of its earnings, dividends, analyst recommendations, valuation, institutional ownership, risk and profitability. Profitability This table […]
BVC | Complete BATM Advanced Communications Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.